Related by context. Frequent words. (Click for all words.) 78 Phase Ib 77 Phase 1b 75 Phase III 75 multiple ascending dose 75 phase IIb 74 Phase 2b study 74 Phase 2a 73 Phase 2a clinical 73 Phase II 73 Phase IIa clinical 71 Phase 2b 71 Phase 71 Phase IIa trial 71 Phase 2a trial 71 Phase 2b trial 71 single ascending dose 71 Phase IIa 70 Phase IIb 70 Phase III clinical 70 dose escalation trial 70 Phase 2b clinical 70 Phase IIb clinical 69 dose escalation study 68 pivotal Phase III 68 Phase IIb trial 65 dose escalation 64 randomized Phase 64 confirmatory Phase 3 64 Phase III pivotal 63 pivotal Phase 63 pharmacokinetic 63 IMGN# 63 initiate Phase 63 safety tolerability 63 AP# [003] 62 blind randomized placebo 62 placebo controlled 62 tolerability 62 IDX# 62 Phase III clinical trials 62 Phase III trials 62 clinical trial 61 Zerenex 61 multicenter randomized double 61 randomized placebo controlled 61 blind randomized 61 pharmacodynamic 61 tolerated dose MTD 61 randomized controlled clinical 61 RG# [001] 61 IND enabling 60 randomized #:# 60 pharmacokinetics 60 double blind placebo 60 dose limiting toxicities 60 pharmacokinetic profile 60 PRX # 60 laquinimod 60 RDEA# 59 pharmacodynamics 59 HGS ETR1 59 NGX# 59 denufosol 59 ISIS # 59 ofatumumab 59 HspE7 59 XL# [003] 59 tolerability profile 58 randomized controlled 58 blinatumomab 58 randomized clinical 58 ZYBRESTAT 58 CoFactor 58 CRx 58 Initiates Phase 58 investigational compound 58 preclinical studies 58 Clinical Study 58 CAPACITY 58 randomized double 57 blind placebo controlled 57 ALTU 57 DSMB 57 INCB# [002] 57 unblinded 57 Phase IV 57 ALN RSV# 57 label dose escalation 57 mipomersen 57 immunogenicity 57 multicenter 57 AEZS 57 monotherapy 57 LEVADEX 56 mg dose 56 carfilzomib 56 sunitinib 56 PF # [001] 56 ASA# 56 clinical trials 56 GRN#L